Tempus AI earnings and guidance shift investor focus
Tempus AI (TEM) just delivered third quarter results that paired higher sales and revenue with a sharply smaller net loss, while management also raised full year 2026 revenue guidance.
The latest update gives investors fresh numbers to work with. Sales for the quarter came in at US$303.47 million, revenue reached US$411.54 million, and the loss narrowed to US$14.85 million compared with a year earlier.
Tempus AI shares have reacted strongly to the latest update, with a 1-day share price return of 7.98% and a 90-day share price return of 46.11% from a last close of US$76.05. The 1-year total shareholder return of 6.27% points to momentum building mainly in the shorter term.
Scan beyond Tempus AI and line up other healthcare AI stocks that are showing strong momentum with our curated list of 35 healthcare AI stocks.
The question now is whether Tempus AI’s sharp swing higher reflects a reset in sentiment after the raised 2026 outlook or a reassessment of what this business is worth based on the numbers.
Most Popular Narrative: 0% Overvalued
Tempus AI last closed at $76.05, almost exactly in line with the most followed narrative fair value of $75.68, which frames the recent guidance upgrade as largely priced in already.
My original thesis on Tempus AI was that this isn’t simply another AI software company. It is building a healthcare data platform where diagnostics generate data, that data improves its AI products, and better products attract more customers and generate even more data.
See why 30 investors see Tempus AI as 0% overvalued.
Result: Fair Value of $75.68 (ABOUT RIGHT)
Still, the Tempus AI story can be knocked off course if the Personalis acquisition proves harder to integrate than expected or if debt pressures tighten flexibility.
Find out about the key risks to this Tempus AI narrative.
Next Steps
Sentiment on Tempus AI is split, with clear concerns on one side and real optimism on the other, so move quickly, review the underlying numbers, and weigh both 2 key rewards and 2 important warning signs.
Looking for more Tempus AI sized opportunities?
If the Tempus AI story has sharpened your focus, do not stop here. Broaden your watchlist and pressure test your ideas with a few targeted screens.
- Zero in on quality companies trading below what the numbers suggest using our curated set of 39 high quality undervalued stocks.
- Prioritise resilience by reviewing a list of solid balance sheet and fundamentals (24 results) that can better handle shocks and funding pressures.
- Hunt for potential future leaders hidden off the radar with a focused group of 19 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com